Skip to content

Clinical trials

Observational Cardiomyopathy, Dilated trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Dilated Phase: Observational Country / region: Canada Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20111
20132
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Unknown status2
Active, not recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
McGill University Health Centre/Research Institute of the McGill University Health Centre3
Wayne State University2
Carelon Research1
Tenaya Therapeutics1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Dilated8
Cardiomyopathy, Hypertrophic4
Cardiomyopathy, Restrictive2
Aortic Valve Insufficiency1
Aortic Valve Stenosis1
Cardiomyopathies1
Coronary Artery Disease1
Heart Defects, Congenital1
Heart Failure1
Mitral Valve Insufficiency1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.